Previous 10 | Next 10 |
BOSTON, Jan. 08, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed against Assertio Holdings, Inc. (NASDAQ: ASRT) for securities law violations. Investors who purchased shares and have lost money are encouraged to contact the firm to learn more about how they might recover those ...
2024-01-08 00:03:36 ET Summary Assertio Holdings has dropped substantially and is down more than 70% in the past year. Assertio Holdings appears to have been oversold based on quantitative factors. It trades at a very low enterprise value to revenue ratio compared to its peers. ...
2024-01-03 09:39:03 ET More on Assertio Holdings Assertio: Major Insider Selling Make It A Must Sell Assertio Holdings Inc. (ASRT) Q3 2023 Earnings Call Transcript For further details see: Assertio Holdings announces departure of CEO Dan Peisert
Dan Peisert Stepping Down as CEO Board member Heather Mason Appointed Interim CEO LAKE FOREST, Ill., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company that acquires...
2023-12-25 14:06:34 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today’s backdrop of a predicted fall in interest rates, as well as the expectation that indices like the S&P 500 will surge higher, has some important considerations for penny ...
2023-12-16 04:30:00 ET Summary The Russell 2000 is experiencing an earnings recession, with negative growth expected to continue into Q4. Q3 earnings season saw a positive surprise, with blended earnings growth improving by 430 bps to -9.9% y/y. Earnings and revenue momentum l...
2023-11-21 15:58:15 ET Summary Insider selling in Assertio raises red flags and erodes trust in management's statements. The magnitude and frequency of insider sales cast doubt on the company's trajectory and prompt a cautious reevaluation. Deep value investing requires contin...
LAKE FOREST, Ill., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company that acquires, commercializes and develops safe and effective therapies that make a difference in the lives of ...
2023-11-09 12:48:14 ET Gainers: Intelligent Bio Solutions ( INBS ) +149% . Pineapple Financial ( PAPL ) +87% . Ramaco Resources ( METC ) +34% . Tempest Therapeutics ( TPST ) +30% . Fitell Corp ( FTEL ) +32% . Honest Company (...
2023-11-09 10:00:37 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector a...
News, Short Squeeze, Breakout and More Instantly...
Assertio Therapeutics Inc. Company Name:
ASRT Stock Symbol:
NASDAQ Market:
Assertio Therapeutics Inc. Website:
2024-07-03 07:15:03 ET H.C. Wainwright analyst issues BUY recommendation for ASRT on July 3, 2024 06:04AM ET. ASRT was trading at $1.15 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Buy recommendati...
LAKE FOREST, Ill., June 05, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Ajay Patel, Chief...
LAKE FOREST, Ill., May 29, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced that its Board of...